Your browser doesn't support javascript.
loading
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Borzillo, Valentina; Scipilliti, Esmeralda; Pezzulla, Donato; Serra, Marcello; Ametrano, Gianluca; Quarto, Giuseppe; Perdonà, Sisto; Rossetti, Sabrina; Pignata, Sandro; Crispo, Anna; Di Gennaro, Piergiacomo; D'Alesio, Valentina; Arrichiello, Cecilia; Buonanno, Francesca; Mercogliano, Simona; Russo, Antonio; Tufano, Antonio; Di Franco, Rossella; Muto, Paolo.
Afiliación
  • Borzillo V; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Scipilliti E; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Pezzulla D; Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Italy.
  • Serra M; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Ametrano G; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Quarto G; Department of Uro-Gynecological, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Perdonà S; Department of Uro-Gynecological, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Rossetti S; Departmental Unit of Clinical and Experimental Uro-Andrologic Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Pignata S; Departmental Unit of Clinical and Experimental Uro-Andrologic Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Crispo A; Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Di Gennaro P; Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • D'Alesio V; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Arrichiello C; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Buonanno F; LB Business Services SRL, Rome, Italy.
  • Mercogliano S; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Russo A; Department of Diagnostic Imaging and Radiation Oncology, University "Federico II" of Naples, Napoli, Italy.
  • Tufano A; Department of Maternal-Child and Urological Sciences, Policlinico Umberto I Hospital, Sapienza University, Rome, Italy.
  • Di Franco R; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
  • Muto P; Department of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
Front Oncol ; 13: 1270498, 2023.
Article en En | MEDLINE | ID: mdl-38023175
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia